Bionano Genomics, Inc. announced the appointment of Hannah Mamuszka and Yvonne Linney, PhD, to its board of directors. Junfeng Wang, who originally joined the company’s board as a representative of Legend Capital, a private equity firm that invested in the company before its initial public offering, has resigned as member of the board. Hannah Mamuszka is the founder and Chief Executive Officer of Alva10. Yvonne Linney founded Linney BioConsulting, an advisory and strategy development firm in the life sciences industry, in January 2019. Yvonne Linney founded Linney BioConsulting, an advisory and strategy development firm in the life sciences industry, in January 2019. Dr. Linney has served as a strategic advisor to General Automation Laboratory Technologies (GALT) since November 2019, SRI International since June 2019, the California Life Sciences Institute since March 2019, and to Tag.bio, Inc. since January 2019.